EU reg to halt export of death penalty drug

European drug officials are spreading cheer to U.S. death row inmates. A regulation that goes into effect tomorrow fortifies the decision already made by some EU drug suppliers individually: It prohibits the export of thiopental for use in executions. But you know the pharma supply chain. Nebraska officials just got hold of some of the drug "via a middleman," to the outrage of manufacturer Naari in Switzerland. CEO Prithi Kochhar wants it returned. Story

Suggested Articles

The partnership aims to make the production of vaccines that use adenovirus as vectors more cost-effective and contamination-free.

The FDA hit New Jersey-based CMO Tris Pharma with a warning letter, citing significant violations.

Celltrion remains optimistic it will get U.S. approval for its two biosimilar drugs, Rituxan and Herceptin, by the end of the year.